ChemicalBook > CAS DataBase List > MIDECAMYCIN

MIDECAMYCIN

Product Name
MIDECAMYCIN
CAS No.
35457-80-8
Chemical Name
MIDECAMYCIN
Synonyms
medemycin;medecamycin;mydecamycin;sf837;Aboren;Myoxam;Midecin;Momicin;Macropen;SF 837A1
CBNumber
CB5175530
Molecular Formula
C41H67NO15
Formula Weight
813.97
MOL File
35457-80-8.mol
More
Less

MIDECAMYCIN Property

Melting point:
155℃ -156℃
Boiling point:
874℃
alpha 
D23 -67° (c = 1 in ethanol)
Density 
1.1651 (rough estimate)
refractive index 
1.6220 (estimate)
Flash point:
>110°(230°F)
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
solubility 
Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly)
form 
Solid
pka
6.9 in 50% aq ethanol
color 
White to Off-White
Water Solubility 
Soluble in methanol or ethanol. Insoluble in water
InChIKey
DMUAPQTXSSNEDD-INMHWYRMNA-N
More
Less

Safety

RTECS 
OH4730600
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H413May cause long lasting harmful effects to aquatic life

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
017648
Product name
Midecamycin
Packaging
1g
Price
$460
Updated
2021/12/16
Usbiological
Product number
257342
Product name
Midecamycin
Packaging
500mg
Price
$468
Updated
2021/12/16
TRC
Product number
M343250
Product name
Midecamycin(>85%)
Packaging
10g
Price
$1190
Updated
2021/12/16
AK Scientific
Product number
R025
Product name
Mydecamycin
Packaging
25mg
Price
$104
Updated
2021/12/16
ChemScene
Product number
CS-5909
Product name
Midecamycin
Purity
>98.0%
Packaging
100mg
Price
$108
Updated
2021/12/16
More
Less

MIDECAMYCIN Chemical Properties,Usage,Production

Description

Midecamycin, a macrolide antibiotic having a 16-membered lactone ring, was found in the culture broth of Streptomyces mycarofaciens by Meiji Seika Kaisha in 1971. Under specific culture conditions, it is produced by the organism as a single component. Midecamycin shows almost the same antimicrobial spectrum and activity as kitasamycin. Although its serum and urine concentrations are low, it distributes in tissues at high concentration following oral administration.

Chemical Properties

White Solid

Originator

Medemycin,Meiji Seika,Japan,1974

Uses

A broad spectrum antibiotic

Uses

A 16-membered ring macrolide antibiotic used in ophthalmology as well as other medical fields.

Definition

ChEBI: Midecamycin is an organic molecular entity.

Manufacturing Process

The SF-837 strain, namely Streptomyces mycarofaciens identified as ATCC No. 21454 was inoculated to 60 liters of a liquid culture medium containing 2.5% saccharified starch, 4% soluble vegetable protein, 0.3% potassium chloride and 0.3% calcium carbonate at pH 7.0, and then stir-cultured in a jarfermenter at 28°C for 35 hours under aeration. The resulting culture was filtered directly and the filter cake comprising the mycelium cake was washed with dilute hydrochloric acid.
The culture filtrate combined with the washing liquid was obtained at a total volume of 50 liters (potency 150 mcg/ml). The filtrate (pH 8) was then extracted with 25 liters of ethyl acetate and 22 liters of the ethyl acetate phase was concentrated to approximately 3 liters under reduced pressure. The concentrate was diluted with 1.5 liters of water, adjusted to pH 2.0 by addition of 5N hydrochloric acid and then shaken thoroughly. The aqueous phase was separated from the organic phase and this aqueous solution was adjusted to pH 8 by addition of 3N sodium hydroxide and then extracted with 800 rnl of ethyl acetate. The resulting ethyl acetate extract was then shaken similarly together with 500 ml of aqueous hydrochloric acid to transfer the active substances into the latter which was again extracted with 400 ml of ethyl ether at pH 8.The ether extract was dried with anhydrous sodium sulfate and concentrated under reduced pressure to give 16.5 g of light yellow colored powder.
12 g of this crude powder were dissolved in 200 ml of ethyl acetate and the solution was passed through a column of 600 ml of pulverized carbon which had been impregnated with ethyl acetate. The development was carried out using ethyl acetate as the solvent and the active fractions of eluate were collected to a total volume of 2,500 ml, which was then evaporated to dryness under reduced pressure to yield 5 g of a white colored powder. This powder was dissolved in 10 ml of benzene and the insoluble matters were filtered out. The filtered solution in benzene was then subjected to chromatographic isolation by passing through a column of 700 ml of silica gel which had been impregnated with benzene. The development of the active substances adsorbed on the silica gel was effected using a solvent system consisting of benzene-acetone (4:1), and the eluate was collected in fractions of each 20 ml. The active fractions No. 90-380 which gave a single spot in alumina thin layer chromatography and which could be recognized as containing the SF- 837 substance purely in view of the Rf-value of the single spot were combined together to a total volume of 4,000 ml, and then concentrated under reduced pressure to yield 1.5 g of white colored powder of a melting point of 122°C to 124°C which was found by analysis to be the pure SF-837 substance free base.

Therapeutic Function

Antibacterial

Pharmaceutical Applications

A naturally occurring metabolite of Streptomyces mycarofaciens, supplied as the native compound and as midecamycin acetate for oral administration.
It is rapidly and extensively metabolized and is said to exhibit less toxicity than earlier macrolides. It is of limited availability.

MIDECAMYCIN Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MIDECAMYCIN Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
BOC Sciences
Tel
16314854226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
9713
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6962
Advantage
56
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
AlliChem, LLC
Tel
--
Fax
--
Email
sales@allichemllc.com
Country
United States
ProdList
6516
Advantage
60
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
2A PharmaChem USA
Tel
--
Fax
--
Email
sales@2apharmachem.com
Country
United States
ProdList
6137
Advantage
39
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
APAC Pharmaceutical, LLC
Tel
--
Fax
--
Email
sales@apacpharma.com
Country
United States
ProdList
6322
Advantage
38
Chem-Impex International, Inc.
Tel
--
Fax
--
Country
United States
ProdList
6730
Advantage
64
ChemPacific Corporation
Tel
--
Fax
--
Email
sales@chempacific.com
Country
United States
ProdList
6891
Advantage
51
MP Biomedicals, Inc.
Tel
--
Fax
--
Country
United States
ProdList
6561
Advantage
81
BOSCHE SCIENTIFIC, LLC
Tel
--
Fax
--
Email
Sales@BoscheSci.com
Country
United States
ProdList
6477
Advantage
55
More
Less

View Lastest Price from MIDECAMYCIN manufacturers

.GZ HONESTCHEM CO.,LTD
Product
Midecamycin 35457-80-8
Price
US $1.00/g
Min. Order
300g
Purity
99.8%
Supply Ability
20 TONS
Release date
2021-07-09
Baoji Guokang Healthchem co.,ltd
Product
MIDECAMYCIN 35457-80-8
Price
US $238.10/g
Min. Order
100g
Purity
99%
Supply Ability
200kg
Release date
2021-06-10
Career Henan Chemical Co
Product
MIDECAMYCIN 35457-80-8
Price
US $1.00/g
Min. Order
1g
Purity
≥98%
Supply Ability
g/kg/Ton
Release date
2019-12-25

35457-80-8, MIDECAMYCINRelated Search:


  • antibioticsf837
  • sf837
  • turimycinp(sub3)
  • LEUCOMYCIN V 3,4B-DIPROPIONATE
  • Aboren
  • Leucomycin V, 3,4B-dipropanoate (9CI)
  • Macropen
  • Medecamycin A1
  • Medemycin A1
  • Midecamycin A1
  • Midecin
  • Momicin
  • Mydecamycin A1
  • Myoxam
  • Normicina
  • NSC 154011
  • Oxacyclohexadecane, leucomycin V deriv.
  • Rubimycin
  • SF 837A1
  • Turimycin P3
  • YL 704B1
  • medecamycin
  • MIDECAMYCIN
  • MIDECAMYCINE
  • midecamycin from streptomyces*mycarofaciens
  • MIDECAMYCIN FROM STREPTOMYCES &
  • Leucomycin V 3,4''-dipropionate
  • Leucomycin V 3,4<sup>B</sup>-dipropionate
  • Midecamycin, >98%
  • propanoic acid [(11Z,13E)-6-[[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[[(2S,4R,5R,6R)-4-hydroxy-4,6-dimethyl-5-(1-oxopropoxy)-2-oxanyl]oxy]-6-methyl-2-oxanyl]oxy]-10-hydroxy-5-methoxy-9,16-dime
  • antibioticsf837a1
  • antibioticyl704b1
  • espinomycina
  • leucomycinv,3,4(supb)-dipropanoate
  • medemycin
  • midecamycina(sub1)
  • mydecamycin
  • platenomycinb1
  • DMUAPQTXSSNEDD-BJXZGPOLSA-N
  • LeucoMycin V 3,4B-Dipropanoate
  • MoMicine
  • MIDECAMYCIN USP/EP/BP
  • Midecamycin (>85%)
  • (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-4-(dimethylamino)-5-hydroxy-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-(propanoyloxy)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl propanoate
  • (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4R,5S,6R)-4-(Dimethylamino)-3-hydroxy-5-(((2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-(propionyloxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-4-yl propionate
  • (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4R,5S,6R)-4-(Dimethylamino)-3-hydroxy-5-(((2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-(propionyloxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-ox
  • Midecamycin, 10 mM in DMSO
  • 35457-80-8
  • 3557-80-8
  • C41H67NO15
  • Pharmaceuticals
  • Carbohydrates & Derivatives
  • Chiral Reagents
  • Intermediates & Fine Chemicals